Precision Optics (POCI) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Sep 3, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q3 FY2026, filed May 13, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the POCI SEC filings page.
Precision Optics (POCI) reported $19.1M in revenue for fiscal year 2025, down 0.1% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Stable sales have become a worsening cost-and-cash problem, with margin compression overwhelming the company's operating base.
Revenue was essentially flat from FY2024 to FY2025, while gross margin fell from30.4% to17.8% . Operating margin then widened from-14.3% to-29.1% , showing that fixed operating costs were not being absorbed by the sales base.
In FY2025, net loss was
Debt declined from
Financial Health Signals
Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Precision Optics's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Precision Optics held $1.8M in cash, cash equivalents and investments at the end of fiscal year 2025, and its operations used $3.5M of cash that year. Cash Runway ranks emerging companies on the size of that balance against the outflow behind it, and Precision Optics scores 21/100 among other emerging companies.
Precision Optics had 8M shares outstanding at the end of fiscal year 2025, against 6M in fiscal year 2024. Dilution ranks emerging companies on how fast that count has grown over three years, where a slower rise is the better one, and Precision Optics scores 43/100 among other emerging companies.
Precision Optics spent $1.2M on research and development in fiscal year 2025, which was 4.7% of its operating costs that year. R&D Intensity ranks emerging companies on the share of operating costs that goes into research, and Precision Optics scores 23/100 among other emerging companies.
Precision Optics reported revenue of $19.1M in fiscal year 2025, against $19.1M in fiscal year 2024. Revenue Progress ranks emerging companies on the three-year path of that line, and Precision Optics scores 37/100 among other emerging companies.
Precision Optics's operations used $3.5M of cash in fiscal year 2025, against $2.7M used in fiscal year 2024. Burn Trend ranks emerging companies on which way that figure has moved over three years, and Precision Optics scores 1/100 among other emerging companies.
Precision Optics's cash, cash equivalents and investments came to $1.8M at the end of fiscal year 2025, against $7.5M of total liabilities. Balance Sheet ranks emerging companies on that comparison, and Precision Optics scores 28/100 among other emerging companies.
Precision Optics scores 0.06, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($47.8M) relative to total liabilities ($7.5M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Precision Optics passes 3 of 9 financial strength tests. 1 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, neither operating efficiency signal passes.
Precision Optics reported a net loss of $5.8M while operations used $3.5M of cash. With neither figure positive, the ratio between the two carries no quality signal.
Precision Optics reported an operating loss of $5.6M against $227K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.
Key Financial Metrics
Earnings & Revenue
Precision Optics generated $8.7M in revenue in Q3 2026. This represents an increase of 108.0% from the same quarter a year earlier. Against the prior quarter it is up 18.2%.
Precision Optics's EBITDA was $11K in Q3 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 100.6% from the same quarter a year earlier. Against the prior quarter it is up 100.7%.
Precision Optics reported -$108K in net income in Q3 2026. This represents an increase of 94.8% from the same quarter a year earlier. Against the prior quarter it is up 93.9%.
Precision Optics earned -$0.01 per diluted share (EPS) in Q3 2026. Against the prior quarter it is up 95.7%.
Cash & Balance Sheet
Precision Optics held $10.7M in cash against $856K in long-term debt as of Q3 2026.
Not reported for Q3 2026.
Not reported for Q3 2026.
Margins & Returns
Precision Optics's gross margin was 23.6% in Q3 2026, indicating the percentage of revenue retained after direct costs. This is up 13.6 percentage points from the same quarter a year earlier. Against the prior quarter it is up 20.8 percentage points.
Precision Optics's operating margin was -0.7% in Q3 2026, reflecting core business profitability. This is up 47.9 percentage points from the same quarter a year earlier. Against the prior quarter it is up 22.9 percentage points.
Precision Optics's net profit margin was -1.2% in Q3 2026, showing the share of revenue converted to profit. This is up 48.9 percentage points from the same quarter a year earlier. Against the prior quarter it is up 22.9 percentage points.
Precision Optics's ROE was -0.5% in Q3 2026, measuring profit generated per dollar of shareholder equity. This is up 15.4 percentage points from the same quarter a year earlier. Against the prior quarter it is up 18.6 percentage points.
Capital Allocation
Precision Optics invested $267K in research and development in Q3 2026. This represents an increase of 26.5% from the same quarter a year earlier. Against the prior quarter it is up 7.1%.
Not reported for Q3 2026.
Not reported for Q3 2026.
POCI Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Revenue | $8.7M+108.0% | $7.4M+62.8% | $6.7M+59.2% | $6.2M+31.1% | $4.2M-20.2% | $4.5M-6.2% | $4.2M-2.9% | $4.7M-6.1% |
| Cost of Revenue | $6.7M+76.5% | $7.2M+107.2% | $5.7M+86.2% | $5.4M+45.8% | $3.8M+11.4% | $3.5M+2.5% | $3.1M+7.8% | $3.7M+13.1% |
| Gross Profit | $2.1M+392.0% | $205K-80.9% | $946K-15.3% | $799K-22.0% | $418K-77.5% | $1.1M-26.3% | $1.1M-23.7% | $1.0M-41.8% |
| R&D Expenses | $267K+26.5% | $250K-21.5% | $312K-22.2% | $228K-35.6% | $211K+9.6% | $318K+43.3% | $401K+88.3% | $355K-8.0% |
| SG&A Expenses | $1.9M-17.4% | $1.7M+2.1% | $2.2M+13.6% | $1.9M-4.9% | $2.2M+16.7% | $1.7M-14.0% | $2.0M+18.6% | $2.0M+1.9% |
| Operating Income | -$64K+96.8% | -$1.7M-91.5% | -$1.6M-27.9% | -$1.4M0.0% | -$2.0M-688.4% | -$910K-29.2% | -$1.2M-207.7% | -$1.4M-120.7% |
| EBITDA | $11K+100.6% | -$1.7M-93.8% | -$1.5M-27.6% | -$1.3M-0.2% | -$2.0M-858.2% | -$861K-32.1% | -$1.2M-238.9% | -$1.3M-131.7% |
| Interest Expense | $35K-39.9% | $38K-35.5% | $42K-35.0% | $45K-15.6% | $58K-0.1% | $60K+9.2% | $64K+8.8% | $53K+2.6% |
| Income Tax | $9K | N/A | N/A | N/A | $0 | N/A | N/A | N/A |
| Net Income | -$108K+94.8% | -$1.8M-83.6% | -$1.6M-24.8% | -$1.4M+0.6% | -$2.1M-561.3% | -$970K-27.8% | -$1.3M-182.3% | -$1.4M-1368.0% |
| EPS (Basic) | -$0.01+96.7% | -$0.23-53.3% | -$0.210.0% | -$0.18+25.0% | -$0.30-500.0% | -$0.15-15.4% | -$0.21-162.5% | -$0.24-1100.0% |
| EPS (Diluted) | -$0.01 | -$0.23-53.3% | -$0.210.0% | -$0.18+25.0% | -$0.30-500.0% | -$0.15-15.4% | -$0.21-162.5% | -$0.24-1100.0% |
| Diluted Shares (Avg) | 8M | 8M+21.5% | 8M+24.1% | N/A | 7M+14.0% | 6M+4.7% | 6M+2.5% | N/A |
POCI Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $33.7M+71.7% | $22.9M+30.8% | $22.4M+29.9% | $19.8M+17.0% | $19.6M+7.4% | $17.5M-1.1% | $17.2M-9.6% | $16.9M-14.3% |
| Current Assets | $21.4M+114.7% | $10.4M+32.9% | $9.9M+31.3% | $10.1M+41.3% | $10.0M+18.8% | $7.8M+0.1% | $7.5M-18.7% | $7.1M-27.8% |
| Cash & Equivalents | $10.7M+319.2% | $881K+314.9% | $1.4M+119.0% | $1.8M+337.7% | $2.5M+175.4% | $212K-78.5% | $636K-53.6% | $405K-86.1% |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $3.7M+0.8% | $4.3M+10.8% | $3.9M+12.1% | $3.6M+24.2% | $3.7M+21.1% | $3.8M+24.1% | $3.5M+16.5% | $2.9M+3.3% |
| Accounts Receivable | $6.6M+92.1% | $4.9M+38.9% | $4.2M+34.1% | $4.3M+22.3% | $3.4M-18.9% | $3.5M-0.1% | $3.1M-31.1% | $3.5M-9.3% |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Goodwill | $8.8M0.0% | $8.8M0.0% | $8.8M0.0% | $8.8M0.0% | $8.8M0.0% | $8.8M0.0% | $8.8M0.0% | $8.8M0.0% |
| Total Liabilities | $13.6M+110.7% | $13.6M+68.8% | $11.5M+61.4% | $7.5M+10.0% | $6.4M-8.1% | $8.0M+25.9% | $7.1M-3.7% | $6.8M-11.0% |
| Current Liabilities | $10.2M+103.5% | $10.0M+55.2% | $7.6M+42.8% | $6.2M+25.4% | $5.0M-2.3% | $6.4M+48.7% | $5.3M+4.1% | $4.9M-6.7% |
| Non-Current Liabilities | $3.4M+136.0% | $3.6M+123.0% | $3.8M+117.8% | $1.4M-28.8% | $1.4M-23.8% | $1.6M-21.6% | $1.8M-21.6% | $1.9M-20.4% |
| Long-Term Debt | $856K-40.4% | $1.0M-37.9% | $1.1M-34.5% | $1.3M-32.1% | $1.4M-19.9% | $1.6M-16.0% | $1.7M-14.7% | $1.9M-12.7% |
| Total Equity | $20.1M+52.6% | $9.3M-1.5% | $10.9M+7.8% | $12.3M+21.8% | $13.2M+17.0% | $9.5M-16.3% | $10.1M-13.3% | $10.1M-16.4% |
| Retained Earnings | -$60.5M-8.9% | -$60.4M-12.9% | -$58.6M-11.6% | -$57.0M-11.3% | -$55.6M-11.6% | -$53.5M-8.1% | -$52.5M-7.8% | -$51.2M-6.1% |
POCI Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$723K+61.4% | -$256K+67.5% | $78K+124.6% | -$569K+41.7% | -$1.9M-774.4% | -$787K-556.6% | -$319K+76.8% | -$976K-60.7% |
| Depreciation & Amortization | $76K+21.2% | $74K+50.8% | $65K+35.0% | $53K-5.7% | $62K+19.2% | $49K-6.6% | $48K-6.3% | $56K+4.7% |
| Stock-Based Compensation | $248K-56.0% | $162K-47.4% | $302K+101.9% | N/A | $563K+118.0% | $308K-19.4% | $149K+37.4% | N/A |
| Capital Expenditures | N/A | N/A | N/A | $46K+297.4% | $127K+16.8% | $30K-75.4% | $24K-20.9% | $12K+260.5% |
| Free Cash Flow | N/A | N/A | N/A | -$615K+37.7% | -$2.0M-519.6% | -$817K-238.4% | -$343K+75.6% | -$988K-61.7% |
| Investing Cash Flow | $49K+155.1% | -$96K-201.2% | -$302K-974.0% | -$84K-608.5% | -$90K+19.4% | -$32K+74.9% | -$28K+35.4% | -$12K-13626.7% |
| Financing Cash Flow | $10.5M+143.7% | -$158K-140.0% | -$158K-127.4% | -$121K-125.9% | $4.3M+1531.1% | $396K+390.2% | $577K+515.5% | $468K-84.0% |
Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.
POCI Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 23.6%+13.6pp | 2.8%-20.9pp | 14.2%-12.4pp | 12.9%-8.8pp | 10.0%-25.5pp | 23.6%-6.4pp | 26.6%-7.3pp | 21.7%-13.3pp |
| Operating Margin | -0.7%+47.9pp | -23.6%-3.5pp | -23.9%+5.8pp | -21.9%+6.8pp | -48.7%-43.8pp | -20.1%-5.5pp | -29.7%-20.3pp | -28.8%-16.5pp |
| Net Margin | -1.2%+48.9pp | -24.2%-2.7pp | -24.5%+6.7pp | -22.7%+7.2pp | -50.1%-44.0pp | -21.4%-5.7pp | -31.2%-20.5pp | -29.9%-28.0pp |
| Return on Equity | -0.5%+15.4pp | -19.1%-8.9pp | -15.0%-2.1pp | -11.4%+2.6pp | -15.9%-13.1pp | -10.2%-3.5pp | -12.9%-9.0pp | -14.0%-13.2pp |
| Return on Assets | -0.3%+10.4pp | -7.8%-2.2pp | -7.3%+0.3pp | -7.1%+1.2pp | -10.7%-8.9pp | -5.5%-1.2pp | -7.6%-5.2pp | -8.3%-7.8pp |
| Current Ratio | 2.10+0.1x | 1.05-0.2x | 1.29-0.1x | 1.64+0.2x | 1.99+0.4x | 1.22-0.6x | 1.41-0.4x | 1.45-0.4x |
| Debt-to-Equity | 0.04-0.1x | 0.11-0.1x | 0.10-0.1x | 0.11-0.1x | 0.11-0.1x | 0.170.0x | 0.170.0x | 0.190.0x |
| Asset Turnover | 0.260.0x | 0.32+0.1x | 0.30+0.1x | 0.310.0x | 0.21-0.1x | 0.260.0x | 0.240.0x | 0.280.0x |
| FCF Margin | N/A | N/A | N/A | -10.0%+11.0pp | -47.8%-41.6pp | -18.0%-13.0pp | -8.2%+24.3pp | -20.9%-8.8pp |
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Precision Optics POCI | FY2025 | $19.1M | -$5.8M | -30.3% | $47.8M | 26/100 |
| Retractable Tech RVP | FY2025 | $38.3M | -$12.6M | -32.8% | $21.6M | 24/100 |
| Milestone Scient MLSS | FY2025 | $9.0M | $5.7M | 63.8% | $41.2M | 27/100 |
| Nephros Inc NEPH | FY2025 | $18.8M | $1.2M | 6.3% | $45.8M | 53/100 |
| Harvard Biosci HBIO | FY2025 | $86.5M | -$56.7M | -65.5% | $37.3M | 37/100 |
| Nexgel Inc NXGL | FY2025 | $11.4M | -$3.0M | -26.3% | $3.4M | 37/100 |
Where Precision Optics Ranks
Frequently Asked Questions
What is Precision Optics's annual revenue?
Precision Optics (POCI) reported $19.1M in total revenue for fiscal year 2025. This represents a -0.1% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Precision Optics's revenue growing?
Precision Optics (POCI) revenue declined by 0.1% year-over-year, from $19.1M to $19.1M in fiscal year 2025.
Is Precision Optics profitable?
No, Precision Optics (POCI) reported a net income of -$5.8M in fiscal year 2025, with a net profit margin of -30.3%.
What is Precision Optics's EBITDA?
Precision Optics (POCI) had EBITDA of -$5.3M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Precision Optics have?
As of fiscal year 2025, Precision Optics (POCI) had $1.8M in cash and equivalents against $1.3M in long-term debt.
What is Precision Optics's gross margin?
Precision Optics (POCI) had a gross margin of 17.8% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Precision Optics's operating margin?
Precision Optics (POCI) had an operating margin of -29.1% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Precision Optics's net profit margin?
Precision Optics (POCI) had a net profit margin of -30.3% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Precision Optics's return on equity (ROE)?
Precision Optics (POCI) has a return on equity of -47.1% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Precision Optics's free cash flow?
Precision Optics (POCI) recorded an outflow of $3.8M in free cash flow during fiscal year 2025. This represents a -27.7% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Precision Optics's operating cash flow?
Precision Optics (POCI) recorded an outflow of $3.5M in operating cash flow during fiscal year 2025, representing cash used by core business activities.
What are Precision Optics's total assets?
Precision Optics (POCI) had $19.8M in total assets as of fiscal year 2025, including both current and long-term assets.
What are Precision Optics's capital expenditures?
Precision Optics (POCI) invested $227K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does Precision Optics spend on research and development?
Precision Optics (POCI) invested $1.2M in research and development during fiscal year 2025.
What is Precision Optics's current ratio?
Precision Optics (POCI) had a current ratio of 1.64 as of fiscal year 2025, which is generally considered healthy.
What is Precision Optics's debt-to-equity ratio?
Precision Optics (POCI) had a debt-to-equity ratio of 0.11 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Precision Optics's return on assets (ROA)?
Precision Optics (POCI) had a return on assets of -29.2% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Precision Optics's P/E ratio?
Precision Optics (POCI) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (trailing 12 months to March 31, 2026). The market capitalization is $47.8M as of Sep 3, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Precision Optics's price-to-sales ratio?
Precision Optics (POCI) trades at 1.7x sales, its market capitalization divided by revenue of $28.9M revenue, trailing 12 months to March 31, 2026. The market capitalization is $47.8M as of Sep 3, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
How does Precision Optics's liquidity compare with its operating cash outflow?
At the end of fiscal year 2025, Precision Optics (POCI) held $1.8M in cash, cash equivalents and investments, and reported an operating cash outflow of $3.5M over that year. Dividing the one by the other, the reported balance equals about 6 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.
What is Precision Optics's Altman Z-Score?
Precision Optics (POCI) has an Altman Z-Score of 0.06, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Precision Optics's Piotroski F-Score?
Precision Optics (POCI) has a Piotroski F-Score of 3 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Precision Optics's earnings high quality?
Precision Optics (POCI) reported a net loss of $5.8M while operations used $3.5M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Precision Optics cover its interest payments?
Precision Optics (POCI) reported an operating loss of $5.6M against $227K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Precision Optics?
Precision Optics (POCI) scores 26 out of 100 on our Financial Health Score, indicating weak standing within its emerging companies peer group. The score is a 0-100 composite of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.